Acadia pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4)

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) today announced that on may 15, 2024, the compensation committee of acadia's board of directors (the “committee”) granted inducement awards consisting of non-qualified stock options to purchase 57,252 shares of common stock and 33,675 restricted stock units (“rsus”) to twenty-two new employees under acadia's 2023 inducement plan. the compensation committee approved the awards as an inducement material to the new employees' e.
ACAD Ratings Summary
Quant
ACAD Quant Ranking
Sector
Industry
Quant Rating
Quant Score